Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Interventional × Sarcoma, Kaposi × talimogene laherparepvec × Clear all

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Conditions

Melanoma 15 Sarcoma 8 Breast Neoplasms 5 Carcinoma, Merkel Cell 4 Triple Negative Breast Neoplasms 3 Neoplasm Metastasis 3 Carcinoma, Squamous Cell 3 Mycosis Fungoides 2 Lymphoma, T-Cell, Cutaneous 2 Carcinoma, Basal Cell 2 Squamous Cell Carcinoma of Head and Neck 1 Skin Neoplasms 1 Sezary Syndrome 1 Sarcoma, Kaposi 1 Recurrence 1 Rectal Neoplasms 1 Pleural Effusion, Malignant 1 Peritoneal Neoplasms 1 Pancreatic Neoplasms 1 Paget Disease, Extramammary 1 Neurofibromatosis 1 1 Neurofibromatoses 1 Neurofibroma 1 Muir-Torre Syndrome 1 Microcystic adnexal carcinoma 1 Lymphoma, T-Cell 1 Lymphoma, Large-Cell, Anaplastic 1 Lung Neoplasms 1 Liposarcoma 1 Leiomyosarcoma 1

Interventions

Doxorubicin 10 Zidovudine 7 Vincristine 7 Bleomycin 7 Nivolumab 5 Liposomes 5 Interferon alpha-2 5 pembrolizumab 4 liposomal doxorubicin 4 Semaxinib 4 Paclitaxel 4 Nelfinavir 4 Etoposide 4 tecogalan 3 pomalidomide 3 Specimen Handling 3 Ritonavir 3 Magnetic Resonance Spectroscopy 3 Filgrastim 3 Biopsy 3 Bevacizumab 3 technetium-diethylenetriaminepentaacetic acid-mannosyl-dextran 2 sargramostim 2 interferon alfa-n1 2 Valganciclovir 2 Propranolol 2 Indinavir 2 Docetaxel 2 Didanosine 2 Daunorubicin 2

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT04065152 2022-06-10

KAPVEC

Assistance Publique - Hôpitaux de Paris

Phase 2 Unknown

Sarcoma, Kaposi

Data powered by HemOnc (CC BY 4.0) Colophon ⚡